Evidence map›Paper›PMID 25467503›Full record

ArticleAnalytica chimica acta2015

Glycoprofiling as a novel tool in serological assays of systemic sclerosis: a comparative study with three bioanalytical methods.

Ludmila Klukova, Tomas Bertok, Miroslava Petrikova, Alena Sediva, Danica Mislovicova, Jaroslav Katrlik, Alica Vikartovska, Jaroslav Filip, Peter Kasak, Anita Andicsová-Eckstein and 5 more

Abstract readComparative Study
In one paragraph

Article in Analytica chimica acta, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Glycan and lectin biosensors.Essays in biochemistry · 2016
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Ludmila KlukovaDepartment of Glycobiotechnology, Institute of Chemistry, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 845 38, Slovakia.
Tomas BertokDepartment of Glycobiotechnology, Institute of Chemistry, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 845 38, Slovakia.
Miroslava PetrikovaDepartment of Glycobiotechnology, Institute of Chemistry, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 845 38, Slovakia.
Alena SedivaDepartment of Glycobiotechnology, Institute of Chemistry, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 845 38, Slovakia.
Danica MislovicovaDepartment of Glycobiotechnology, Institute of Chemistry, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 845 38, Slovakia.
Jaroslav KatrlikDepartment of Glycobiotechnology, Institute of Chemistry, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 845 38, Slovakia.
Alica VikartovskaDepartment of Glycobiotechnology, Institute of Chemistry, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 845 38, Slovakia.
Jaroslav FilipDepartment of Glycobiotechnology, Institute of Chemistry, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 845 38, Slovakia.
Peter KasakCenter for Advanced Materials, Qatar University, P.O. Box 2713, Doha, Qatar; Department for Biomaterial Research, Polymer Institute, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 845 41, Slovakia.
Anita Andicsová-EcksteinDepartment of Synthesis and Characterization of Polymers, Polymer Institute, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 845 41, Slovakia.
Jaroslav MosnáčekDepartment of Synthesis and Characterization of Polymers, Polymer Institute, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 845 41, Slovakia.
Jozef LukáčNational Institute of Rheumatic Diseases, Nábr. I. Krasku 4, Piešt'any 921 12, Slovakia.
Jozef RovenskýNational Institute of Rheumatic Diseases, Nábr. I. Krasku 4, Piešt'any 921 12, Slovakia.
Richard ImrichLaboratory of Human Endocrinology, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Vlárska 3, Bratislava 833 06, Slovakia.
Jan TkacDepartment of Glycobiotechnology, Institute of Chemistry, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 845 38, Slovakia. Electronic address: Jan.Tkac@savba.sk.
Institute of Chemistry of the Slovak Academy of Sciences · SKSlovak Academy of Sciences · SKNational Institute of Rheumatic Diseases · SK

Funding

European Research Council 311532
6 · The paper itself

Abstract

Systemic sclerosis (SSc) is an autoimmune disease seriously affecting patient's quality of life. The heterogeneity of the disease also means that identification and subsequent validation of biomarkers of the disease is quite challenging. A fully validated single biomarker for diagnosis, prognosis, disease activity and assessment of response to therapy is not yet available. The main aim of this study was to apply an alternative assay protocol to the immunoassay-based analysis of this disease by employment of sialic acid recognizing lectin Sambucus nigra agglutinin (SNA) to glycoprofile serum samples. To our best knowledge this is the first study describing direct lectin-based glycoprofiling of serum SSc samples. Three different analytical methods for glycoprofiling of serum samples relying on application of lectins are compared here from a bioanalytical point of view including traditional ELISA-like lectin-based method (ELLA), novel fluorescent lectin microarrays and ultrasensitive impedimetric lectin biosensors. Results obtained by all three bioanalytical methods consistently showed differences in the level of sialic acid present on glycoproteins, when serum from healthy people was compared to the one from patients having SSc. Thus, analysis of sialic acid content in human serum could be of a diagnostic value for future detection of SSc, but further work is needed to enhance selectivity of assays for example by glycoprofiling of a fraction of human serum enriched in antibodies for individual diagnostics.

Indexed as

Biosensing TechniquesImmunoassayProtein Array AnalysisAdultDielectric SpectroscopyElectrodesEnzymes, ImmobilizedFemaleGlycoproteinsHumansMiddle AgedN-Acetylneuraminic AcidPlant LectinsProtein BindingRibosome Inactivating ProteinsSambucus nigraEnzymes, ImmobilizedGlycoproteinsN-Acetylneuraminic AcidPlant LectinsRibosome Inactivating ProteinsSambucus nigra lectinsElectrochemical impedance spectroscopyEnzyme-linked lectin assayLectinLectin microarraySialic acidSystemic sclerosis

Identifiers

PMID25467503
PMCPMC4883648
OpenAlexW2077500248

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.